CMS has selected 15 new drugs for the next round of Medicare Part D price negotiations, according to a press release from HHS ...

For an extended-release formulation given once daily to offer any advantage in terms of patient convenience, better safety profile due to reduced peak concentrations and/or better or equivalent ...